Fatih Yanar

Fatih Yanar serves as an Assistant Professor at Bogazici University, conducting interdisciplinary research at the intersection of pharmaceutical engineering and cardiovascular genetics. His work targets critical challenges in drug delivery systems and heart disease diagnostics through innovative technical approaches.

Education:

• Bachelor's: Pamukkale University
• Master's: Istanbul University
• Ph.D.: University of Southampton

Research Focus: Dr. Yanar's program spans two high-impact domains. In nanomedicine, he pioneers continuous-flow reactor technology for synthesizing liposomes and silver nanoparticles, enabling precise size control and scalable production without post-processing. This approach overcomes traditional limitations in drug carrier manufacturing. Concurrently, his cardiovascular genetics research investigates single nucleotide polymorphisms in metabolic pathways (e.g., carnitine-shuttle genes) to identify biomarkers for early coronary artery disease detection. Both streams emphasize translational solutions for pharmaceutical and clinical applications.

Publication Trends: Recent articles (2018-2020) reveal a strategic integration of engineering and molecular biology. His nanotechnology work demonstrates reactor innovations for industrial-scale nanomaterial synthesis, while genetic studies establish methodological frameworks for case-control analysis of atherosclerosis. Collectively, these publications highlight a consistent focus on scalable biomedical solutions with diagnostic and therapeutic implications.

Research Operations: Dr. Yanar's laboratory employs continuous-flow reactor systems for nanoparticle production alongside genetic analysis techniques for patient cohort studies. This dual-platform setup facilitates cross-disciplinary collaboration between chemical engineers and medical researchers, though specific team members and grant funding aren't detailed in available materials.